Skip to main content

Table 2 Prior treatments and interventions

From: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

Prior treatments / interventions

N (%)

Surgery / intervention

 Thoracoscopy +/− intervention

53 (32%)

 No surgery / intervention

37 (23%)

 Cardiothoracic surgery

31 (19%)

 Other intervention

11 (7%)

 Unknown surgery / intervention

32 (20%)

First line anticancer treatment (n = 164)

 Platinum + pemetrexed

117 (71%)

 Clinical trial

21 (13%)

 MVP (mitomycin C, vinblastine, cisplatin)

15 (9%)

 Other chemotherapy regimen

6 (4%)

 Incomplete / missing information

5 (3%)

Second line anticancer treatment (n = 117, 71%)

 Clinical trial

58 (50%)

 Rechallenge platinum and pemetrexed

27 (23%)

 Other chemotherapy regimen

26 (22%)

 Incomplete / missing information

6 (5%)

Median total treatments prior to referral

2 (range 0–6)